Optimizing patient selection for secondary cytoreductive surgery in recurrent endometrial cancer
Virginia Vargiu(Agostino Gemelli University Polyclinic), Francesco Fanfani(Agostino Gemelli University Polyclinic), Ettore Di Stefano(Università Cattolica del Sacro Cuore), Alessandro Gioè(Agostino Gemelli University Polyclinic), Roberto Berretta(University of Parma), Lucia Tortorella(Agostino Gemelli University Polyclinic), Francesco Cosentino, Andrea Rosati(Agostino Gemelli University Polyclinic), Diana Giannarelli(Agostino Gemelli University Polyclinic), Valerio Gallotta(Università Cattolica del Sacro Cuore), Giovanni Scambia(Università Cattolica del Sacro Cuore), Martina Corrado(Università Cattolica del Sacro Cuore), Vito Andrea Capozzi(University of Parma)
Cited by 4
Related Papers
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
|Annals of Oncology|2016|398
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
|Clinical Cancer Research|2019|240
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated <i>BRAF</i>-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial
|Journal of Clinical Oncology|2022|231
Vaginal Cuff Dehiscence in a Series of 12,398 Hysterectomies
|Obstetrics and Gynecology|2012|179